Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
468.00    -6.50 (-1.37%)
Bid:
467.50
Ask:
467.70
Spread: 0.20 (0.043%)
Market Cap: £5.83b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Director/PDMR Shareholding

20 Apr 2023 11:55

RNS Number : 9352W
Melrose Industries PLC
20 April 2023
 

20 April 2023

Melrose Industries PLC (the "Company")

Notification of Transactions of Persons Discharging Managerial Responsibility in accordance with Article 19(1) of the Market Abuse Regulation (2014/596/EU) ("MAR")

The Company announces that it has been informed that on 20 April 2023, Alice Dilnot, the wife of the Chief Operating Officer, Peter Dilnot, purchased 32,111 Ordinary Shares of 160/7 pence in the Company at a price of 379.84 pence per share. These shares were purchased pursuant to a determination of the Remuneration Committee on 1 March 2023 (made in accordance with the terms of the bonus deferral scheme in the Directors' Remuneration Policy) that 50% of the 2022 annual bonus (post-tax) awarded to the Chief Operating Officer, Peter Dilnot, would be required to be deferred into Ordinary shares of the Company for a period of two years.

Following this transaction, Mr Dilnot and persons closely associated with him hold an interest of 65,444 Ordinary Shares in the Company, representing approximately 0.00484% of the issued share capital of the Company.

Enquiries:

Montfort Communications:

 

+44 (0) 20 3514 0897

 

Nick Miles, Charlotte McMullen

 

+44 (0) 7739 701634 / +44 (0) 7921 881 800

 

Notification of Transactions of Persons Discharging Managerial Responsibility in accordance with Article 19(1) of MAR

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name of natural person

Peter Dilnot / Alice Dilnot

2.

Reason for the notification

a)

Position / status

Chief Operating Officer / Person Closely Associated

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer

a)

Full name of the entity

Melrose Industries PLC

b)

Legal Entity Identifier code

213800RGNXXZY2M7TR85

4.

Details of the transaction(s)

a)

Description of the financial instrument, type of instrument

Ordinary shares of 160/7 pence each

b)

Identification Code

GB00BNGDN821

c)

Nature of the transaction

Acquisition of ordinary shares of 160/7 pence each

d)

Currency

GBP - British Pound

e)

Price(s) and volume(s)

 

Price

Volume

GBP 3.7984

32,111

 

 

f)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

32,111

 

GBP 121,970.42

g)

Date of the transaction

20 April 2023

h)

Place of the transaction

London Stock Exchange

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFEISLIIFIV
Date   Source Headline
4th Mar 20217:00 amRNSFinal Results
21st Jan 20214:45 pmRNSResult of Meeting
4th Jan 20217:00 amRNSAppointment of Executive Director
29th Dec 202012:30 pmRNSPosting of Circular and Notice of General Meeting
8th Dec 20204:05 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSTrading Statement
25th Sep 20209:51 amRNSDirector/PDMR Shareholding
3rd Sep 20207:00 amRNSHalf-year Report
4th Aug 20207:00 amRNSFinancing Update
22nd Jul 20207:00 amRNSTrading Statement
4th Jun 20202:36 pmRNSDirector/PDMR Shareholding
28th May 20207:00 amRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSDirector/PDMR Shareholding
7th May 202012:56 pmRNSResult of AGM
7th May 20207:00 amRNSTrading Statement
6th May 20204:56 pmRNSHolding(s) in Company - Replacement
5th May 20204:10 pmRNSHolding(s) in Company
5th May 20204:09 pmRNSHolding(s) in Company
4th May 20207:00 amRNSHolding(s) in Company
1st May 20205:05 pmRNSHolding(s) in Company
28th Apr 20205:02 pmRNSRegulatory Filing – LR.9.2.6E
15th Apr 202011:03 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 202011:04 amRNSAnnual Report and Notice of AGM
31st Mar 20209:57 amRNSStandard annual confirmation of POUs
30th Mar 20204:25 pmRNSTrading Statement
19th Mar 20209:42 amRNSHolding(s) in Company
16th Mar 20207:00 amRNSDirector/PDMR Shareholding
13th Mar 20203:33 pmRNSHolding(s) in Company
10th Mar 20209:46 amRNSDirector/PDMR Shareholding
9th Mar 202011:13 amRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
19th Nov 20197:00 amRNSTrading Statement
18th Oct 20194:30 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSAppointment of Independent Non-Executive Director
5th Sep 20197:00 amRNSHalf-year Report
14th Jun 20194:00 pmRNSDirector/PDMR Shareholding
29th May 20194:04 pmRNSDirector/PDMR Shareholding
9th May 201912:49 pmRNSResult of AGM
9th May 20197:00 amRNSTrading Statement
5th Apr 201912:55 pmRNS2018 Annual Report and Notice of AGM
3rd Apr 20191:20 pmRNSCapital Markets Day
1st Apr 20195:43 pmRNSPost-Offer Undertakings Report
18th Mar 20194:41 pmRNSDirector/PDMR Shareholding
11th Mar 20195:01 pmRNSDirector/PDMR Shareholding
7th Mar 20197:00 amRNSFinal Results
6th Mar 20197:00 amRNSSundry Disposals
19th Dec 20187:00 amRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.